No Nicotine!..Hannmi Pharmaceutical to expand its non-smoking campaign
No Nicotine!..Hannmi Pharmaceutical to expand its non-smoking campaign
  • Kim Min-jee
  • 승인 2018.11.12 13:28
  • 댓글 0
이 기사를 공유합니다

Hannmi Pharmaceutical is planning to expand its non-smoking campaign that has been held since 2015. 

Hannmi Pharmaceutical announced on November 12 that it will expand and operate its anti-smoking campaign to commemorate the launch of the anti-smoking drug, "Nocotine". 

The Nocotine, which will be released this month, is the only anti-smoking drug licensed as oxalate among the Vareniclines, a special drug developed exclusively by Hannmi Pharmaceutical Technology.

"As a pharmacist, we should contribute to reducing smoking, which is fatal to our health." Hannmi Pharmaceutical Executive Director Lim Jong-ho said. "This campaign is a meaningful program that can keep you healthy. Hannmi Pharmaceutical plans to continue to support the campaign to become a long-term corporate culture."

Hannmi Pharmaceutical has become a pharmaceutical company with two types of antismoking drugs used in the government's anti-smoking treatment program.

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • URL: / Editorial Div. 02-578-0434 / 010-2442-9446. Email:
  • Publisher: Monica Younsoo Chung. CEO: Lee Kap-soo. Editor: Jung Yeon-jin. Juvenile Protection Manager: Yeon Choul-woong.
  • IT Times Canada: Willow St. Vancouver BC, Canada / 070-7008-0005.
  • Copyright(C) Korea IT Times, Allrights reserved.